QCM
XERS icon

Quantinno Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Quantinno Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
42,466
+11,495
+37% +$73.4K ﹤0.01% 3164
2026
Q1 		$180K Buy
30,971
+6,275
+25% +$41.6K ﹤0.01% 3211
2025
Q4 		$194K Buy
24,696
+7,002
+40% +$55.1K ﹤0.01% 3060
2025
Q3 		$144K Buy
17,694
+5,123
+41% +$34K ﹤0.01% 2838
2025
Q2 		$58.7K Buy
+12,571
New +$57.6K ﹤0.01% 2552

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Quantinno Capital Management's XERS Position: Q2 2026 in Review

Quantinno Capital Management increased its Xeris Biopharma Holdings (XERS) stake by 37% in Q2 2026, buying an estimated $73.4K and bringing the position to 42,466 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

Quantinno Capital Management first reported a position in XERS in Q2 2025 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Quantinno Capital Management held 42,466 shares of Xeris Biopharma Holdings worth $336K as of Q2 2026.
  • Quantinno Capital Management bought 11,495 Xeris Biopharma Holdings shares in Q2 2026, an estimated $73.4K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3164 holding.
  • Quantinno Capital Management first reported a position in Xeris Biopharma Holdings in Q2 2025 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.